Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Richard Stravitz"'
Autor:
Thomas Enke, Daniel Ganger, Jody Rule, Richard Stravitz, Jorge Rakela, Adrian Reuben, Norman Sussman, Anne Larson, Shannan Tujios, Nathan Bass, Sherry Livingston, Valerie Durkalski-Mauldin, William M. Lee
Publikováno v:
Journal of Hepatology. 77:S394-S395
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d826c9b758a946d00688a7b0daade60c
https://doi.org/10.1016/s0168-8278(22)01137-0
https://doi.org/10.1016/s0168-8278(22)01137-0
Autor:
Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis, Robert S. Brown, Michael W. Fried, Norah A. Terrault, Jacqueline G. O'Leary, Hugo E. Vargas, Alexander Kuo, Eugene Schiff, Mark S. Sulkowski, Richard Gilroy, Kymberly D. Watt, Kimberly Brown, Paul Kwo, Surakit Pungpapong, Kevin M. Korenblat, Andrew J. Muir, Lewis Teperman, Robert J. Fontana, Jill Denning, Sarah Arterburn, Hadas Dvory-Sobol, Theo Brandt-Sarif, Phillip S. Pang, John G. McHutchison, K. Rajender Reddy, Nezam Afdhal, Michael Fried, Kris Kowdley, Norah Terrault, Steve Flamm, John Lake, Greg Everson, Mark Sulkowski, Michael Curry, Rajender Reddy, Hugo Vargas, Andrew Muir, Atif Zaman, Robert Fontana, Jacqueline O'Leary, Obaid Shaikh, Kevin Korenblat, Richard Stravitz, Kymberly Watt, Narayanan Menon, James Bredfeldt, Carlos Romero-Marrero
Publikováno v:
Gastroenterology. 149(3):649-659
Background & Aims There are no effective and safe treatments for chronic hepatitis C virus (HCV) infection of patients who have advanced liver disease. Methods In this phase 2, open-label study, we assessed treatment with the NS5A inhibitor ledipasvi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38f770582ba5f4fe742799ee0643a7f
Autor:
Valeria R, Mas, Daniel G, Maluf, Richard, Stravitz, Catherine I, Dumur, Bradly, Clark, Cheryl, Rodgers, Andrea, Ferreira-Gonzalez, Robert A, Fisher
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 10(5)
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death in the world. The present study aimed to investigate the genes involved in viral carcinogenesis and tumor progression in liver transplant recip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c45df6cd70e56cf6189cf1e4d92821cb
https://pubmed.ncbi.nlm.nih.gov/15108252
https://pubmed.ncbi.nlm.nih.gov/15108252